Back
ESC2025 Premium Access

Contemporary treatment patterns and outcomes of endovascular therapy in octogenarians and older with peripheral artery disease: a multicentric analysis of 1980 patients from the RECCORD registry

Session: Adjuvant strategies to peripheral artery disease
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor D. Pinsdorf (Essen, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor David Pinsdorf

University of Duisburg-Essen - West-German Heart and Vascular Center, Essen (Germany)
0 follower

6 more presentations in this session

GLP-1 RA vs DPP4i in patients with prior major adverse limb evets

Speaker: Ms C. Chen (Tao-Yuan, TW)

Access
Abstract
Slides
Video
Like
Thumbnail

Effectiveness and safety of rivaroxaban vs apixaban in patients with Atrial Fibrillation and Peripheral Artery Disease

Speaker: Doctor L. Dari (Bordeaux, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Association of baseline and longitudinal changes in non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio with cardiovascular outcomes in peripheral artery disease

Speaker: Doctor Z. Liu (Sha Tin, HK)

Access
Abstract
Slides
Video
Like
Thumbnail

Serum ferritin level could predict wound healing in chronic limb-threatening ischemia patients after endovascular therapy

Speaker: Doctor J. Nakamura (Osaka, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Effect of behaviour change interventions on walking capacity, clinical outcomes, and quality of life in intermittent claudication: insights from the OPTIMA systematic review and meta-analysis

Speaker: Doctor U. Abaraogu (Enugu, NG)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Adjuvant strategies to peripheral artery disease

Speakers: Doctor D. Pinsdorf, Ms C. Chen, Doctor L. Dari, Doctor Z. Liu, Doctor J. Nakamura...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources